Cancer arises through the accumulation of somatic mutations over time. Understanding the 11 sequence of mutation occurrence during cancer progression can assist early and accurate 12 diagnosis and improve clinical decision-making. Here we employ Long Short-Term Memory 13 networks (LSTMs), a class of recurrent neural network, to learn the evolution of a tumor through an 14 ordered sequence of mutations. We demonstrate the capacity of LSTMs to learn complex dynamics 15 of the mutational time series governing tumor progression, allowing accurate prediction of the 16 mutational burden and the occurrence of mutations in the sequence. Using the probabilities learned 17 by the LSTM, we simulate mutational data and show that the simulation results are statistically 18 indistinguishable from the empirical data. We identify passenger mutations that are significantly 19 associated with established cancer drivers in the sequence and demonstrate that the genes carrying 20 these mutations are substantially enriched in interactions with the corresponding driver genes. 21
Tumorigenesis is a multistep process characterized by accumulation of somatic mutations, which 42 contribute to tumor growth, clinical progression, immune escape and the development of drug 43 resistance (1, 2) . The somatic mutations found in a tumor cell are accumulated over the lifetime 44 of the cancer patient, so that some mutations are acquired in early steps of tumorigenesis and 45 even in pre-malignant cells (3). Relatively small subsets of these mutations are established tumor 46 drivers, whereas the remainder are thought to be passengers that do not confer growth advantage 47 or may even negatively affect tumor fitness (4-7). Although molecular and cell biology studies 48 have revealed many mechanistic details of tumorigenesis (4,8-10), our understanding of the 49 tumor evolution dynamics remains limited, presumably, due to the complexity of the process and 50 the abundance of passenger events that could be randomly distributed but might exert various 51 effects on tumor fitness and properties (11, 12) . 52
53
In colorectal cancer, tumor development has been explained by a multistep model of 54 carcinogenesis that describes the progression of a benign adenoma to a malignant carcinoma 55 through a series of well-defined histological stages that are linked to a mutational time series, i.e. 56 the temporal sequence of occurrence of driver mutations (13) (14) (15) (16) . Similar stepwise models have 57 been developed for other types of adenocarcinomas (17,18) although the temporal succession of 58 molecular changes characterizing the progression of these tumors has not been elucidated at the 59 level of confidence it has for colon cancer (19) . Given that the somatic alterations in some 60 tumors can be represented as a multistep sequence of events, we conjectured that time series 61 damage response, and thus, to genome instability and tumorigenesis (38) . Thus, the genes that 133 contribute to mutation load prediction in both types of cancer seem to reveal common biological 134 themes. Moreover, the scores assigned by the LSTM using only the 20 latest mutations (i.e. the 135 20 mutations with the highest order scores) as a sequence are highly correlated with the observed 136 mutational load in all test sets ( Fig. 1B-D) . Using the time series from the earliest time point, 137 however, results in almost random prediction performance with similar number of mutations (SI 138 Appendix, Fig. S2 ), suggesting that the ultimate mutational burden of a tumor depends primarily 139 on mutations that occur late in tumor evolution. Training linear classifiers to predict the 140 mutational load from the same sequences of mutations, or randomly selected mutations (see 141
Methods) resulted in significantly inferior performance compared to the LSTM (Fig. 1E-G) , 142
suggesting that the LSTM networks learn complex dynamics within the mutational data that 143 could not be captured by conventional classification approaches. 144
145
The scores assigned to predict the mutational load are also associated with clinical phenotypes. 146
For the colon cancer test sets, the scores assigned by LSTM trained with the 20 latest mutations 147 in the sequence are significantly higher in samples of primary tumors assigned with poor grade 148 vs. moderate grade, in high vs. low microsatellite instability and in high vs. low CpG island 149 methylation phenotypes ( Fig. 1H-K ). In the lung cancer test set, higher scores are associated with 150 lower progression-free survival (PFS, Fig. 1L ). sequences (X-axis) when starting from the latest ordered mutation, for colon and lung test 156 sets.
the time series (x-axis), and the true mutational load (y-axis, log transformed). 159 (E)-(G) Spearman correlation between the scores assigned by different learning models 160 and the observed mutational load (y-axis) when using different number of mutations from 161 these that are ordered latest in the sequence (up to 50 mutations, x-axis). The dashed lines 162
show the results for classifiers trained on randomly selected mutations (rather than the 163 ordered sequence of mutations that is shown by solid lines). We then explored the possibility of predicting the occurrence of mutations in the course of tumor 174 evolution from other mutations in the time series. To this end, the LSTM networks were trained 175 to predict the occurrence of each mutation in the time series, using the time series of 176 mutations from the latest mutation up to the +1 mutation (thus, predicting earlier mutations 177 from later ones). The occurrence of most mutations in the sequence could be predicted with good 178 accuracy, with the median AUC = 0.88, 0.73 and 0.69 for the first and second colon test sets, and 179 for the lung test set, respectively ( Fig. 2A) . Mutations for which occurrence could not be 180 predicted (AUC < 0.5, 2% and 17% of the mutations in colon and lung cancers, respectively) 181
were significantly less common than those that were readily predictable (Rank-sum P-value = 182 0.001 for colon and 2.4e-106 for lung, SI Appendix, Table S1 ), implying that the occurrence of 183 these low frequency mutations is not linked to tumor progression. 184 185 More unexpected than the poor prediction for low frequency mutations, the prediction accuracy 186 for mutations in known cancer driver genes was significantly lower than that for mutations in all only genes that are frequently mutated (SI Appendix, Fig. S3 ). These findings indicate that the driver mutations that determine the course of tumorigenesis could not be readily predicted from 190 the rest of the mutational landscape of a given tumor type. In contrast, many passenger mutations 191 tend to be linked to specific drivers (39) and thus could be predicted with confidence. Notably, 192 however, the subset of driver mutations for which good prediction accuracy was achieved, 193
included DNA repair genes, such as MLH1, MSH2, MSH6, PMS2 and MUTYH for colon 194 cancer, and DDX5 and CHD1L for lung cancer, conceivably, due to their effect on other 195 mutations in the sequence (SI Appendix, Table S1 ). 196
197
Recently, it has been shown that LSTM recurrent neural networks can be used to generate 198 complex sequences by simply predicting one data point at a time (24). We hence reasoned that 199 similar technique could be utilized to generate the mutational time sequence, and thus could be 200 employed for mutational data reconstruction. We used the LSTM scores to predict the 201 occurrence of each mutation in the time series (from the latest to the earliest), to determine the 202 occurrence of one mutation at a step in a simulated time series (see Methods for details). In this 203 manner, we reconstructed 100 mutational samples for colon cancer, and 100 samples for lung 204 cancer (SI Appendix, Tables S2-3). The K-means clustering analysis did not separate the 205 simulated data from the real data (SI Appendix, Fig. S4A To evaluate the effect of the actual order of the mutations in the sequence function on the 216 prediction of the preceding mutations, we repeated this analysis for the 300 last mutations, in 217 both colon and lung cancers, after randomly permuting the order of mutations in the sequence up of the results with those obtained with the original, ordered sequence of mutations shows a 220 dramatic drop in the prediction accuracy (paired rank-sum P-value<0.06, 0.02 and 9e-6 for colon 221 test set1, colon test set 2 and lung test set, respectively, SI Appendix, Fig. S7 ). This is a strong 222 indication that the actual order of mutations is important for predicting the mutational sequence. 
Predicting associations between major cancer drivers and other genes 246 247
Given that most mutations are predicted with high accuracy from the time sequence, we 248 investigated the possibility that some mutations (currently classified as passenger) might also be 249 predicted from the ordered time sequence of mutations in cancer driver genes which play key 250 roles in tumor development. Mutations that might be predicted through their association with 251 major cancer drivers are of obvious interest because they could potentially contribute to different 252 aspects of tumorigenesis. To explore such potential associations, we selected well characterized, 253 major cancer drivers in each tumor type studied (n=42 for colon and n=26 for lung; see Methods) 254
and utilized the discrete time series of their occurrences to predict the occurrence of other 255 which mutations could be predicted robustly with high AUC from multiple points in the time 257 series of the major drivers (Methods, SI Appendix, Table S4 ). 258
259
Given that these mutations are accurately predicted using a short mutational sequence 260 that includes only the major drivers, we hypothesized that the respective genes interact with 261 these drivers. To further characterize the potential functional connections between the major 262 drivers and the identified associated genes, we first determined which driver contributed to the 263 prediction of each of the identified driver-associated mutations (see Methods) to generate a list of 264 driver-interactor pairs for colon and lung cancers ( Fig. 3A , SI Appendix, Table S5 ). A STRING 265 interactions enrichment analysis (41,42) (see Methods) showed that, for 68 and 39 predicted 266 driver-interactor pairs in colon and lung cancers, respectively, the interaction is validated under 267 the multiple criteria implemented in STRING (hyper-geometric P-value~=0 and 5.2675e-04 for 268 colon and lung, respectively). When the major cancer drivers were analyzed individually, we 269 found significant (P-value <0.05) STRING enrichment between about 22% of both colon and 270 lung cancer major drivers and their predicted interactors, a result that is unlikely to be obtained 271 by chance ( Fig. 3A , permutation P-value <0.001 for both colon and lung). 272
273
The node degrees of the major cancer drivers in the network of STRING-validated 274 interactions vary substantially within the networks inferred for each tumor type and differ 275 between the colon and lung networks for shared drivers, with the mean degree of 3.5 for colon 276 and 3 for lung ( Fig. 3C-D) . In both networks, SMAD4, a gene encoding a protein involved in the 277 TGF-beta signaling pathway (43), is highly connected. Most of the genes connected with 278 SMAD4 in these networks are also involved in TGF-beta signaling but the specific subsets of 279 these genes differ between the colon and lung networks. Several of these interactions have been 280 reported previously. In particular, MAP2K4 has been identified as a conditional tumor 281 suppressor in lung adenocarcinomas but not in colon cancer (44), whereas mutations in HIF1A 282 are associated with the worst prognosis in colon cancer (45); furthermore, HIF1A protein 283 physically interacts with SMAD4 under hypoxic conditions in colon cancer cell lines (46). The 284 degree of TP53 is considerably higher in the lung cancer network than in the colon cancer 285 network, possibly, due to different TP53 mutants that are observed in these tumors (47) that have SMAD4, ATM and NF1 belong to the same strongly connected network module, whereas major 288 tumor-specific cancer drivers such as APC (colon) and EGFR (lung) are disconnected. Next, we systematically assessed whether the predicted interactors of the major cancer drivers 304 are involved in the same or similar processes with the corresponding drivers. Using GO 305 enrichment (49,50), we find that, for both colon and lung cancers, all major drivers with 306 predicted interactors share a significant (with hyper-geometric P-value<0.05) overlap of the sets 307 of GO processes with their predicted interactors ( Fig. 4A-B ). This level of enrichment in shared 308 processes is unlikely to be reached by chance (Permutation P<0.001 for both colon and lung). 309 310 For the 13 major drivers that are shared between colon and lung cancers, we identified 1119 GO 311 significantly enriched processes (enrichment P-value < 0.01, SI Appendix, Table S6 ). For the 312 predicted interactors of these major drivers, 240 GO processes are highly enriched in the case of 313 colon cancer, and 229 processes are highly enriched for lung cancer. Of these, 133 GO processes 314 are shared between the interactors from colon and lung cancers (hyper-geometric P-value ~=0), 315 and among them, 34 GO processes are shared with the set of processes enriched among drivers 316
(hyper-geometric P-value = 0.02, Fig. 4C , SI Appendix, Table S6 ). Among the GO processes 317 that are shared between these major cancer drivers and their interactors, are cell motility 318 pathways, regulation of cell development, differentiation and growth factor stimulation, and 319 mesenchyme development processes. It appears plausible that the predicted interactions of 320 diverse genes with the major drivers promote tumor growth and aggressiveness through the 321 modulation of those processes. 322 cancer driver that are significantly shared with its predicted interactors, for colon and 326 lung cancers, respectively. The dot plots show the percentage of overlap of GO processes between each major driver and its predicted interactors (the red bar shows the mean of 328 this distribution). 329 (C) Heatmaps for GO processes enriched with the shared colon and lung major drivers 330
and their interactors (presented are the interactors that are most strongly associated with 331 these GO processes; for full information, see SI Appendix, Table S6 ). 332 333 334
Driver-interactor modules are associated with patients' survival 335 336
We next investigated the bipartite network of major drivers and their predicted 337
interactors. In an attempt to infer the contributions of these interactions to tumor fitness through 338 patients' survival, we first sought to identify modules of major drivers that share interactors. To 339 this end, we performed a heuristic search for driver modules, aiming to cover the maximum 340 number of drivers in each tumor type. Specifically, we searched for the maximum partition of 341 each tumor graph into disjoint sub-graphs, such that each sub-graph is complete (more precisely, 342 the relation between the modules of drivers and interactors are complete; see Methods for 343 details). In colon cancer, we identified three mutually exclusive modules of drivers (with 344 mutually exclusive pairwise interactions) which together cover 22 of the 23 major colon cancer 345 drivers with predicted interactions (all but the DCC gene), and 47 interactors ( Fig. 5A-C) . For 346 each module, we then identified the TCGA colon samples in which the given module is highly 347 mutated (see Methods for details). We performed Kaplan Meier survival analysis comparing the 348 survival curves between samples with high vs. low number of mutations of the predicted 349 interactors within each module, conditional on the drivers in the respective module are highly 350 mutated. Strikingly, we found that the high mutation rate of interactors of each of the three 351 modules is associated with poor survival when the driver component of the module is mutated 352 ( Fig. 5D-F) . For some of these shared interactors, we also find that individual mutations are 353 significantly associated with lower survival rate in the context where their driver module is 354 highly mutated ( Fig. 5G-I ). Among these, SIX4 expression has been shown to correlate with For the lung adenocarcinoma mutational data, we detected two mutually exclusive modules of 373 drivers (with mutually exclusive pairwise interactions) that together cover 10 of the 18 major 374 lung cancer drivers with predicted interactions, with 47 interactors of these drivers (Fig. 6A-B) . 375
Similarly to the observations on colon cancer, a high number of mutations in the interactors of 376 each driver module is associated with poor survival in samples where the corresponding drivers 377 are mutated (Fig. 6C,E) and with lower progression-free survival (Fig. D,F) . For four of the 378 predicted interactors of module 1 (but none for module 2), we also find that some of the 379 individual interacting mutations are significantly associated with lower survival rate when 380 drivers from this module are mutated ( Fig. 6G) . One of such interactors is EPN1, an Epsin 381 family member shown to regulate tumors progression (53). mutations. This phenomenon starts from transformation of normal epithelium to an adenoma, 405 proceeding to in situ carcinoma, and ultimately to invasive and metastatic tumor, where specific 406 mutations mark each step in this tumorigenic transformation (17, 19) . It is hence reasonable to 407 surmise that time series prediction approaches could be valuable when applied to the sequence of 408 these genetic events in tumors. show that the mutational time series could be utilized via LSTM networks to achieve good 414 performance in otherwise difficult prediction tasks. Using the estimated order of mutations burden and clinical phenotypes, could be predicted from a limited number of mutations. The 417 non-linear relations learned by the networks, together with the discrete representation of the data 418 enable performance, that is significantly superior to the previous models built for this task 419 (62,63). The model can learn intricate dynamics of the mutational sequence in tumor evolution, 420 that can subsequently be used for the reconstruction of mutation sequences. When more data 421 becomes available and the relevant neural network models are further refined, similar approaches 422 could be applied to reconstruct data on actual DNA sequences and could thus extensively 423 contribute to our understanding of tumor evolution. It is worth pointing out that applications of 424
LSTMs generally take advantage of much larger data for training because in these, the input 425 alphabet as well as possible labels are from a much larger range, thus substantially increasing the 426 size of the data set required for training. In our analysis, discretizing the mutational data and 427 maintaining discrete labels (i.e. both input size and labels are always of size 2) generates a 428 simple enough problem that can be approached even with limited amounts of data (Table 1) . We 429 also found that LSTM perform much better than linear classifiers, such as Support Vector 430 Machine (SVM), for the prediction of the mutational load. This is likely to be the case because 431 LSTM learn non-linear relationships between mutations in the given sequence, rather than 432 defining a linear separating hyperplane, with the underlining assumption that the mutational load 433 can be predicted using a linear function of mutations. 434
435
A potentially important contribution of this approach is the identification of interactors of the 436 major cancer drivers. Here we predict many such interactors and show that they are significantly 437 enriched with STRING interactions and show non-random overlap of GO processes with the 438 corresponding major drivers. Anecdotally, at least some of the better characterized interactors 439 were found to be involved in the same pathway with the corresponding driver. In contrast, we 440 find that the predicted interactors of each drivers are not located on similar chromosomal arms 441 (SI Appendix, Fig. S8 ), suggesting that these are mostly functional, rather than physical 442
interactions. Furthermore, and most strikingly, we found that mutations in these predicted 443 interactors, in the presence of the corresponding driver mutations, are associated with poor progression. We identified unique modules of major drivers and their interactors for both colon and lung cancer. The strong correlation with patients' survival suggests that these interactions are 447
clinically relevant and if further tested, could potentially be used for patients' stratification and 448 clinical decision-making. The identified interactors can be regarded as secondary drivers whose 449 oncogenic activity is conditional to and associated with the occurrence of mutations in major 450 drivers for the respective cancer types. Hence these conditional drivers could be readily predicted 451 notwithstanding the low accuracy of prediction for most of the major drivers themselves. 452
To summarize, in this work, we present the application of LSTM for learning the stepwise 453 sequence of mutations in tumors. This approach is shown to efficiently tackle several tasks that 454 are not amenable to standard techniques, such as prediction of the occurrence of mutations and 455 reconstruction of mutational data. Our findings reveal a unidirectional relation between driver 456 and passenger mutations: drivers determine the course of tumorigenesis and their occurrence is 457 difficult to predict from the rest of the mutational landscape, whereas passengers are often linked 458 to specific drivers and so can be predicted with confidence. Thus, drivers are indeed in the 459 driver's seat and bring with them a host of associated "passengers", some of which could be 460 secondary, conditional drivers. The present results support the notion that long-term 461 dependencies between genes involved in tumorigenesis and cancer progression are widespread in 462 tumor evolution and can be learned from the mutational sequence using LSTM networks and 463 similar approaches. We show that this notion holds for colon cancer, where the stepwise process 464 of mutation acquisition is established, but also for lung cancer for which such a stepwise model 465 has been suggested but remains controversial. Similar strategies could be readily employed for 466 other tumor types and different types of biological data to advance our understanding of tumor 467 initiation and progression through the dissection of the sequence of evolutionary events. 468 469
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We thank Koonin group members for helpful discussions. Driver mutation lists for lung and colon cancers. The driver mutations for each tumor type 493 were obtained from (70) and https://www.intogen.org (71). The union of the two lists comprised 494 a comprehensive list of cancer drivers for lung and colon cancers (SI Appendix, Table S7 ). 495 first discretize the mutational data such that each sample is assigned a value of 1 for gene if it 499 has a non-synonymous mutation in . For each cancer type, we then consider all genes that are 500 mutated at least once in all datasets used (training and test datasets), resulting in the totals of 501 12,322 mutated genes for colon cancer and 12,327 mutated genes for lung cancer. 502
503
To sort the mutations of colon and lung adenocarcinoma by their estimated temporal order, we 504 evaluate the following function for each TCGA training dataset: 505
= 1 if sample has a mutation in gene . 508
509
We calculate the order score for each considered gene using the TCGA COAD and LUAD 510 datasets that are used for training. Then, we sort the genes in each dataset by the score assigned 511 to them using the training data of the corresponding cancer type. Order scores calculated using 512 the test datasets were found to significantly correlate with that derived from the training set for 513 both colon and lung cancers (SI Appendix, Fig. S9 ). 514 515 Long Short-Term Memory (LSTM) machines. Long Short-Term Memory (LSTM) networks 516 are a type of Recurrent Neural Networks that use a time series as input for various prediction 517 tasks. Each LSTM network unit defines a time in a sequence (the subscript t denotes the 518 mutation that is ordered in the tumor evolution via the order score defined above), and is 519 composed of the following components: All LSTM networks used in this work are sequence-to-label LSTMs with 5 hidden layers, were 539 trained using Adam optimizer (72), where the maximum number of epochs for training was set to 540 100 for the mutational load prediction, and to 10 for all other prediction tasks. These thresholds 541
were selected for the sake of computational feasibility; increasing those is expected to further 542 improve the performance. The mini-batch size used for each training iteration was set to 27, 543 with a standard gradient-clipping threshold set to 1. 544 545 Training LSTMs to predict the mutational load. To predict the overall mutational burden and 546 evaluate the number of mutations in the sequence that are required for this task, we train LSTMs 547 for the sequence up to each timepoint when starting once from the mutation ordered last (going 548 backwards in tumor evolution) and second from the mutation ordered first in the sequence. The 549 2-categorial labels ∈ {0,1} are defining 'low' vs 'high' mutational load, where a sample with 550 'low' mutational load is assigned a label of 0 (if the mutational load of a sample is lower than the 551 median of within a dataset) and 'high' mutational load is assigned a label of 1 (samples with 552 mutational load higher than the median). For each time point , a is trained on the 553 training set using the sequence up (either from the first or the last ordered mutation) and is then 554 applied to the test set to predict the mutational load using the time sequence of mutations up-to . 555
For each time point , the resulting scores (obtained via applying on the sequence of 557 latest mutations in the test) are used to evaluate the performance via two measures: 558
(1) The resulting from a ROC curve, predicting the 'low' vs. 'high' categories in the 559 test. 560
(2) The Spearman rank correlation coefficient between the scores that are assigned 561 to each test sample (denoting a likelihood of it having 'high' mutational load) and the 562 actual mutational load of the sample. 563
564
Training KNN, SVM and logistic regression classifiers to predict the mutational load. KNN 565 (with K=5), SVM (using linear kernel) and logistic regression classifiers were trained on the 566 training sets using: (1) sequences of the latest ordered mutations that were used as input to the 567 LSTMs (up to 50 latest mutations) and (2) sequences of 50 randomly selected mutations. These 568 were trained to predict 'low' vs 'high' mutational load as described for the LSTMs. They were 569 then tested on the test sets, and the resulting classification scores were correlated with the true 570 mutational load via Spearman rank-correlation. 571 572 Training LSTMs to predict the occurrence of succeeding mutations in the time sequence. 573
To predict the occurrence a mutation ordered in the sequence we train LSTM for the sequence 574 starting from the mutation ordered last up-to timepoint + 1. The 2-categorial labels ∈ {0,1} 575 are defining the occurrence of the mutation. The LSTMs were trained to predict the occurrence 576 of a mutation in each time point using the training sets of colon and lung, and test their 577 performance for predicting the occurrence of these mutations in the test sets. 578
579
Training LSTM networks to simulate mutational data. To synthesize mutational data, we use 580 the full mutational data for each cancer type (i.e. the union of training and test sets for each 581 tumor type). We reconstruct 100 simulated mutational samples for each tumor type, one 582 mutation at a step, from the last-ordered mutation to the first; 583
For the mutation ordered last, we randomly assign 1 to of the 100 generated samples, 584
where is the overall frequency (in percent) of this last mutation. 585 to predict the occurrence of from the sequence starting from the mutation ordered last up-to 588 timepoint + 1, using the all datasets of each tumor type. We then apply to the simulated 589 sequence (that has been synthesized up-to time point + 1), to obtain a vector of scores 590 predicting the occurrence of mutation in each reconstructed sample. We then use , the 591 frequency of the ordered mutation in the genuine datasets, and assign 1 to the mutations 592 that were assigned with highest scores by when applied to the reconstructed sequences. Training LSTMs to identify mutations that interact with the major cancer drivers. To learn 598 the association of mutations with the major driver genes in colon and lung adenocarcinomas, we 599 select the driver genes in which mutations are observed frequently in out training sets, within the 600 top 0.1 percentile. These genes are defined as major drivers and are used as an ordered sequence 601 of mutations (n=42 for colon and n=26 for lung, SI Appendix, Table S4 ). The sequence of 602 occurrences of these major drivers is used to predict the occurrence of other mutations, excluding 603 those with very low frequency (genes that are mutated in 3 samples or less in the training data 604 are excluded), as the prediction of those could be obtained easily by chance. To predict the 605 occurrence of each mutation, we trained 42 LSTMs for colon and 26 for lung (using the 606 sequence of major drivers up to each time point). The genes that could be predicted with 607 AUC>0.85 for the test set (using the average AUC for the two test sets of colon) repeatedly, 608 from multiple locations in the sequence of drivers (higher than the average number of locations 609 with good performance), are selected as predicted interactors of the major drivers. A graphical 610 schema describing the steps of this analysis can be found in SI Appendix, Fig. S10 . 611
612
Assigning major drivers to interacting mutations. To investigate which of the major drivers 613 contribute to the prediction of mutations in each driver-interacting gene (and are hence can be 614 predicted to interact with it), we use the scores produced by the LSTMs where the driver-615
interacting gene is well-predicted. We then correlate these scores with the occurrence of each of correlation P-value<0.05) with the LSTM scores predicting a given driver-interacting gene are combined with it into driver-interactor pairs. 619 620 Enrichment with STRING interactions and GO analysis. To investigate whether the pairs of 621 major drivers and their predicted interactors are enriched with established interactions, we 622 performed the following analyses: 623 1) STRING enrichment. Hyper-geometric enrichment analysis was performed for each 624 major driver gene, to find if its LSTM-predicted interactors are enriched with its 625 interactors from the STRING database. 626
2) GO enrichment. For each major driver, we calculated the percentage of its associated 627 interactors that share a significant number of GO processes with it (hyper-geometric 628 P-value <0.05) and the mean percentage of overlapping GO pathways with its 629
interactors. 630
We then calculate an empirical P-value from produced via 1000 repetitions, with drivers 631 randomly assigned to the identified interacting mutations (and same degree, i.e. the number of 632 predicted interactions, preserved for each driver), in order to evaluate the probability of obtaining 633 results with a similar or higher significance level by chance. 634 635 Modules of major drivers and interacting genes. We aim to identify modules of major drivers 636 and their interactors, such that the modules are mutually exclusive in terms of both drivers and 637 interactors (i.e. no shared drivers or interactors between the modules). To cover as many drivers 638 as possible, we created modules via a heuristic search using 10,000 repetitions of the following 639 genetic algorithm. For each repetition, we start with a randomly selected major driver. Then, in 640 each round, we randomly select a major driver that has not yet been added to the module. We 641 then add it to the module if its addition does not decrease the number of mutual module-642 interactors by more than 20%. The round ended when 100 random selections were not added to 643 the current module or when the number of interactors of a module is less than 3. After 10,000 644 repetitions, we investigated the resulting 10,000 modules and selected those that together cover 645 maximal number of major drivers such that the modules were mutually exclusive with respect to 646 both drivers and interactors. 647 Statistical analyses.
